These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 7703548)
1. [Prognostic factors for extratesticular involvement in stage I testicular cancer. Apropos of 58 cases]. Chraibi Y; Culine S; Terrier-Lacombe MJ; Kramar A; Kattan J; Droz JP Bull Cancer; 1994 Apr; 81(4):311-7. PubMed ID: 7703548 [TBL] [Abstract][Full Text] [Related]
2. The value of prognostic factors in the management of stage I nonseminomatous germ cell testicular tumors (NSGCTT). Ondrus D; Goncalves F; Kausitz J; Mat'oska J; Belan V Neoplasma; 1996; 43(3):195-7. PubMed ID: 8841507 [TBL] [Abstract][Full Text] [Related]
3. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of patients with stage I non-seminomatous testicular tumors with general orchiectomy]. Hornák M; Ondrus D Z Urol Nephrol; 1988 Sep; 81(9):541-5. PubMed ID: 2853503 [TBL] [Abstract][Full Text] [Related]
7. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Stenning SP; Parkinson MC; Fisher C; Mead GM; Cook PA; Fossa SD; Horwich A; Jones WG; Newlands ES; Oliver RT; Stenwig AE; Wilkinson PM Cancer; 1998 Oct; 83(7):1409-19. PubMed ID: 9762943 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified? Divrik RT; Akdoğan B; Ozen H; Zorlu F J Urol; 2006 Oct; 176(4 Pt 1):1424-29; discussion 1429-30. PubMed ID: 16952649 [TBL] [Abstract][Full Text] [Related]
9. [Two cases of testicular tumors with high alpha-fetoprotein levels: a case report]. Funahashi M; Tuchiya F; Makiyama K; Sugiura S; Miyoshi Y; Kishida T; Ogawa T; Uemura H; Yao M; Kubota Y Hinyokika Kiyo; 2005 Feb; 51(2):133-7. PubMed ID: 15773370 [TBL] [Abstract][Full Text] [Related]
10. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements. Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394 [TBL] [Abstract][Full Text] [Related]
11. Nonseminomatous germ cell testicular tumors clinical stage I: differentiated therapeutic approach in comparison with therapeutic approach using surveillance strategy only. Ondrus D; Ondrusova M; Hornak M; Matoska J Neoplasma; 2007; 54(5):437-42. PubMed ID: 17688374 [TBL] [Abstract][Full Text] [Related]
12. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Moul JW; McCarthy WF; Fernandez EB; Sesterhenn IA Cancer Res; 1994 Jan; 54(2):362-4. PubMed ID: 8275469 [TBL] [Abstract][Full Text] [Related]
13. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. Nicolai N; Pizzocaro G J Urol; 1995 Sep; 154(3):1045-9. PubMed ID: 7637051 [TBL] [Abstract][Full Text] [Related]
14. A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. Nicolai N; Miceli R; Artusi R; Piva L; Pizzocaro G; Salvioni R J Urol; 2004 Jan; 171(1):172-6. PubMed ID: 14665870 [TBL] [Abstract][Full Text] [Related]
15. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia. Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765 [TBL] [Abstract][Full Text] [Related]
16. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases. Malagón HD; Valdez AM; Moran CA; Suster S Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191 [TBL] [Abstract][Full Text] [Related]
17. Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. Böhlen D; Borner M; Sonntag RW; Fey MF; Studer UE J Urol; 1999 Apr; 161(4):1148-52. PubMed ID: 10081858 [TBL] [Abstract][Full Text] [Related]
18. Sex cord stromal testicular tumors: a clinical series--uniformly stage I disease. Featherstone JM; Fernando HS; Theaker JM; Simmonds PD; Hayes MC; Mead GM J Urol; 2009 May; 181(5):2090-6; discussion 2096. PubMed ID: 19286222 [TBL] [Abstract][Full Text] [Related]
19. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542 [TBL] [Abstract][Full Text] [Related]